UMECRINE AB has a total of 43 patent applications. Its first patent ever was published in 2001. It filed its patents most often in China, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEURMEDIX INC, BAR PHARMACEUTICALS S R L and PRIRODOVEDECKA FAKULTA UK.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 8 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 4 | |
#5 | Canada | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Brazil | 3 | |
#8 | Japan | 3 | |
#9 | Mexico | 2 | |
#10 | India | 1 | |
#11 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Baeckstroem Torbjoern | 17 |
#2 | Lundgren Per | 15 |
#3 | Wang Ming-De | 15 |
#4 | Ragagnin Gianna | 15 |
#5 | Johansson Inga-Maj | 9 |
#6 | Backstrom Torbjorn | 8 |
#7 | Per Lundgren | 6 |
#8 | Torbjoern Baeckstroem | 5 |
#9 | Torbjorn Backstrom | 4 |
#10 | Gianna Ragagnin | 4 |
Publication | Filing date | Title |
---|---|---|
CN103819525A | Steroid compound | |
CN103880909A | Steroidal compound | |
CN104004041A | Steroid compounds | |
CN101585862A | Novel steroids | |
MX2007006032A | Gaba-steroid antagonists and their use for the treatment of cns disorders. | |
CN1607954A | Pregnane steroids for use in the treatment of cns dysfunction |